DOLOBID Drug Patent Profile
✉ Email this page to a colleague
When do Dolobid patents expire, and when can generic versions of Dolobid launch?
Dolobid is a drug marketed by Merck and is included in one NDA.
The generic ingredient in DOLOBID is diflunisal. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the diflunisal profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dolobid
A generic version of DOLOBID was approved as diflunisal by TEVA on July 31st, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DOLOBID?
- What are the global sales for DOLOBID?
- What is Average Wholesale Price for DOLOBID?
Summary for DOLOBID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 120 |
| Patent Applications: | 4,377 |
| DailyMed Link: | DOLOBID at DailyMed |
US Patents and Regulatory Information for DOLOBID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-001 | Apr 19, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-002 | Apr 19, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DOLOBID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-001 | Apr 19, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-002 | Apr 19, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-002 | Apr 19, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-001 | Apr 19, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
